Perspective Therapeutics, Inc. · LSX:A40EDR
Perspective Therapeutics, Inc. shareholders
As of Sep 30, 2026, 114 institutions reported holding Perspective Therapeutics, Inc., 70.0% of its shares. Largest: BlackRock, TCG Crossover Management, LLC and Millennium. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Of the company | Value | Change vs Jun 30 | Filed |
|---|---|---|---|---|---|
| BlackRock | 11.8M | 10.4% | US$32.5M | +2.33M | Nov 13, 2026 |
| TCG Crossover Management, LLC | 7.92M | 6.9% | US$21.8M | No change | Nov 16, 2026 |
| Millennium | 6.19M | 5.4% | US$17M | +1.28M | Nov 16, 2026 |
| Avidity Partners Management LP | 6.07M | 5.3% | US$16.7M | −232K | Nov 16, 2026 |
| Vanguard | 6.03M | 5.3% | US$16.6M | −116K | Nov 13, 2026 |
| Affinity Asset Advisors, LLC | 3.99M | 3.5% | US$11M | −226K | Nov 13, 2026 |
| Citadel | 3.98M | 3.5% | US$10.9M | +173K | Nov 16, 2026 |
| Spruce Street Capital LP | 3.69M | 3.2% | US$10.2M | No change | Nov 13, 2026 |
| Two Sigma | 3M | 2.6% | US$8.26M | +1.45M | Nov 16, 2026 |
| ADAR1 Capital Management, LLC | 2.62M | 2.3% | US$7.2M | +1.41M | Nov 16, 2026 |
| Nantahala Capital Management, LLC | 2.49M | 2.2% | US$6.85M | −2.16M | Nov 13, 2026 |
| Geode Capital | 2.04M | 1.8% | US$5.6M | −421K | Nov 6, 2026 |
| State Street | 2.03M | 1.8% | US$5.57M | −4.02M | Nov 12, 2026 |
| Nicholson Wealth Management Group, LLC | 1.62M | 1.4% | US$4.45M | −1,000 | Nov 9, 2026 |
| Marshall Wace, LLP | 1.48M | 1.3% | US$4.08M | New | Nov 13, 2026 |
| UBS | 1.26M | 1.1% | US$3.47M | +817K | Nov 10, 2026 |
| Dimensional | 1.23M | 1.1% | US$3.37M | +154K | Nov 4, 2026 |
| Yu Fan | 1.06M | 0.92% | US$2.9M | No change | Nov 16, 2026 |
| Hills Bank & Trust Co | 872K | 0.76% | US$2.4M | No change | Nov 10, 2026 |
| Schwab | 831K | 0.73% | US$2.29M | +57,676 | Nov 16, 2026 |
| Northern Trust | 781K | 0.68% | US$2.15M | −10,564 | Nov 16, 2026 |
| Goldman Sachs | 737K | 0.65% | US$2.03M | −996K | Nov 16, 2026 |
| Morgan Stanley | 624K | 0.55% | US$1.72M | −1.29M | Nov 13, 2026 |
| Voya Investment Management LLC | 454K | 0.40% | US$1.25M | +116K | Nov 10, 2026 |
| RBC | 437K | 0.38% | US$1.2M | +429K | Nov 16, 2026 |
| WealthPlan Investment Management, LLC | 404K | 0.35% | US$1.11M | No change | Oct 15, 2026 |
| Bank of America | 373K | 0.33% | US$1.03M | −92,094 | Nov 16, 2026 |
| Wellington | 371K | 0.32% | US$1.02M | +303K | Nov 16, 2026 |
| Nuveen | 359K | 0.31% | US$988K | +22,448 | Nov 10, 2026 |
| BNY | 308K | 0.27% | US$846K | +9,914 | Nov 5, 2026 |
| Seven Fleet Capital Management LP | 296K | 0.26% | US$814K | −36,526 | Nov 16, 2026 |
| Gsa Capital Partners LLP | 295K | 0.26% | US$812K | +1,637 | Nov 16, 2026 |
| Fidelity | 268K | 0.23% | US$737K | −59,252 | Nov 10, 2026 |
| Federated Hermes, Inc. | 227K | 0.20% | US$625K | +10,089 | Nov 12, 2026 |
| Renaissance Technologies | 222K | 0.19% | US$609K | +163K | Nov 12, 2026 |
| BNP Paribas | 220K | 0.19% | US$606K | +99,391 | Nov 12, 2026 |
| Citigroup Inc | 215K | 0.19% | US$591K | −120K | Nov 4, 2026 |
| XTX Topco Ltd | 185K | 0.16% | US$510K | +154K | Nov 16, 2026 |
| Ally Bridge Group (NY) LLC | 164K | 0.14% | US$450K | −580K | Nov 16, 2026 |
| American Century | 147K | 0.13% | US$405K | +26,229 | Nov 20, 2026 |
| Rhumbline Advisers | 135K | 0.12% | US$372K | +11,819 | Nov 10, 2026 |
| Bridgeway Capital Management, LLC | 134K | 0.12% | US$368K | +72,894 | Nov 16, 2026 |
| Barclays | 127K | 0.11% | US$349K | +105K | Nov 6, 2026 |
| JPMorgan | 126K | 0.11% | US$331K | +79,278 | Nov 12, 2026 |
| Empowered Funds, LLC | 123K | 0.11% | US$338K | New | Nov 13, 2026 |
| AllianceBernstein | 109K | 0.10% | US$301K | −10,650 | Nov 16, 2026 |
| Trueblood Wealth Management, LLC | 99,740 | 0.09% | US$274K | No change | Oct 23, 2026 |
| DWS | 88,126 | 0.08% | US$242K | −12,631 | Nov 6, 2026 |
| Taylor & Morgan Wealth Management, LLC | 86,000 | 0.08% | US$237K | +20,000 | Oct 9, 2026 |
| T. Rowe Price | 85,930 | 0.08% | US$237K | No change | Nov 16, 2026 |
This page holds 50 of 114 holders.
Funds
| Holder | Shares | Of the company | Value | Change | As of |
|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 4.04M | 3.5% | US$13.8M | +2.32M | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 3.31M | 2.9% | US$11.3M | No change | Jun 30, 2026 |
| iShares Russell 2000 ETF | 2.65M | 2.3% | US$9.03M | +1.14M | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1.13M | 0.99% | US$3.28M | +511K | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1.02M | 0.89% | US$3.47M | +58,240 | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 978K | 0.86% | US$3.33M | +447K | Jun 30, 2026 |
| iShares Biotechnology ETF | 636K | 0.56% | US$2.17M | −57,223 | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 446K | 0.39% | US$1.76M | +63,267 | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 405K | 0.35% | US$1.6M | +113K | May 31, 2026 |
| iShares Micro-Cap ETF | 347K | 0.30% | US$1.18M | +191K | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 320K | 0.28% | US$1.26M | +24,911 | May 31, 2026 |
| Vanguard Health Care Index Fund | 288K | 0.25% | US$1.14M | −2,447 | May 31, 2026 |
| U.S. Small Cap Portfolio | 270K | 0.24% | US$784K | +160K | Jul 31, 2026 |
| Select Biotechnology Portfolio | 259K | 0.23% | US$1.02M | No change | May 31, 2026 |
| Dimensional U.S. Small Cap ETF | 254K | 0.22% | US$740K | −116K | Jul 31, 2026 |
| Schwab Small-Cap Index Fund | 251K | 0.22% | US$731K | +119K | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 237K | 0.21% | US$690K | +110K | Jul 31, 2026 |
| Nuveen Equity Index Fund | 193K | 0.17% | US$563K | No change | Jul 31, 2026 |
| Master Small Cap Index Series | 193K | 0.17% | US$658K | +99,163 | Jun 30, 2026 |
| Federated Hermes MDT Small Cap Growth Fund | 189K | 0.17% | US$549K | No change | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 169K | 0.15% | US$666K | +43,948 | May 31, 2026 |
| Fidelity Small Cap Value Index Fund | 145K | 0.13% | US$493K | +67,284 | Jun 30, 2026 |
| Nuveen Small Cap Blend Index Fund | 137K | 0.12% | US$400K | +65,498 | Jul 31, 2026 |
| Direxion Daily S&P Biotech Bull 3X Shares | 137K | 0.12% | US$399K | +37,255 | Jul 31, 2026 |
| Vanguard U.S. Momentum Factor ETF | 136K | 0.12% | US$537K | New | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 129K | 0.11% | US$510K | +42,000 | May 31, 2026 |
| Voya Small Company Portfolio | 118K | 0.10% | US$402K | New | Jun 30, 2026 |
| EQ/2000 Managed Volatility Portfolio | 112K | 0.10% | US$382K | +52,524 | Jun 30, 2026 |
| Voya MI Dynamic Small Cap Fund | 106K | 0.09% | US$417K | New | May 31, 2026 |
| Dimensional U.S. Core Equity 2 ETF | 95,830 | 0.08% | US$279K | New | Jul 31, 2026 |
| Avantis U.S. Small Cap Equity ETF | 87,725 | 0.08% | US$346K | +74,533 | May 31, 2026 |
| LVIP State Street Small-Cap Index Fund | 75,600 | 0.07% | US$258K | +33,500 | Jun 30, 2026 |
| BlackRock Advantage SMID Cap Fund, Inc. | 73,326 | 0.06% | US$250K | New | Jun 30, 2026 |
| Schwab U.S. Broad Market ETF | 63,522 | 0.06% | US$250K | +958 | May 31, 2026 |
| EQ/Small Company Index Portfolio | 61,780 | 0.05% | US$211K | +18,280 | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 57,911 | 0.05% | US$197K | No change | Jun 30, 2026 |
| Schwab Total Stock Market Index Fund | 53,471 | 0.05% | US$156K | No change | Jul 31, 2026 |
| Small Cap Index Fund | 53,460 | 0.05% | US$182K | +26,665 | Jun 30, 2026 |
| EQ/AB Small Cap Growth Portfolio | 53,010 | 0.05% | US$181K | +18,280 | Jun 30, 2026 |
| Diversified Equity Alpha Master Portfolio | 52,405 | 0.05% | US$179K | New | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 50,000 | 0.04% | US$171K | −50,000 | Jun 30, 2026 |
| Global X Russell 2000 ETF | 49,345 | 0.04% | US$144K | +23,228 | Jul 31, 2026 |
| U.S. Vector Equity Portfolio | 48,875 | 0.04% | US$142K | New | Jul 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 47,732 | 0.04% | US$163K | No change | Jun 30, 2026 |
| Vanguard Russell 2000 Value Index Fund | 47,669 | 0.04% | US$188K | +4,269 | May 31, 2026 |
| Fidelity ZERO Total Market Index Fund | 44,085 | 0.04% | US$128K | No change | Jul 31, 2026 |
| Biotechnology Ultrasector Profund | 38,484 | 0.03% | US$112K | +7,567 | Jul 31, 2026 |
| MetLife Russell 2000 Index Portfolio | 34,788 | 0.03% | US$119K | +14,651 | Jun 30, 2026 |
| Fidelity ZERO Extended Market Index Fund | 30,537 | 0.03% | US$88,863 | +816 | Jul 31, 2026 |
| Small-Cap Index Portfolio | 29,450 | 0.03% | US$100K | +13,660 | Jun 30, 2026 |
This page holds 50 of 118 holders.
Big stakes
| Holder | Stake | Shares | Date |
|---|---|---|---|
| Chen Yu | 6.90% | 7.92M | Feb 3, 2026 |
| BlackRock, Inc. | 6.80% | 7.78M | Jun 30, 2026 |
| Qatar Investment Authority | 6.20% | 7.07M | Feb 4, 2026 |
| Commodore Capital LP | 5.50% | 6.6M | Sep 30, 2026 |
| Millennium Management LLC | 5.50% | 6.32M | Aug 7, 2026 |
| Avidity Partners Management LP | 5.30% | 6.05M | Feb 20, 2026 |
| Lantheus Holdings, Inc. | 3.90% | 4.74M | Nov 10, 2026 |